2023 Masters of Pediatric Dermatology (MOPD)

Valued Participants and Colleagues, Welcome to the 2023 Masters of Pediatric Dermatology (MOPD)! After 31 years of MOPD, our steadfast commitment to dynamic education remains the same - to provide the most cutting-edge, clinically relevant, and practice-actionable knowledge surrounding pediatric and adolescent dermatology to all pediatric health care practitioners, including dermatologists, pediatric dermatologists, pediatricians, nurse practitioners and physician assistants in pediatric practice.

This year’s conference is a timely collection of the latest updates, treatment pearls, therapeutic masterclasses, trends, and strategies delivered by renowned clinical authorities in the field of pediatric dermatology. Relevant topics covering acne, atopic dermatitis, psoriasis, molluscum contagiosum, pigmented skin lesions, hidradenitis suppurativa, alopecia areata, vitiligo, neonatal care, rare/orphan diseases, and much more are on MOPD’s very comprehensive 2023 agenda.

We are honored to be celebrating the 31st year MOPD which has expanded from a half day meeting to a full TWO day meeting in 2 years.

On behalf of the LiVDerm team and our honorary Chair and Founder, Dr. Lawrence Schachner, please enjoy your stay in Miami Beach, time spent with valued colleagues and friends, and the entire MOPD experience.

Yours In Continued Good Health, The LiVDerm + MOPD Team

8:00 AM – 9:00 AM

AGENDA

THURSDAY FEBRUARY 9, 2023

CME Satellite Breakfast Symposium

A New Age in Pediatric Psoriasis: Case-Based Learning for Inclusive Care

Supported by an educational grant from Arcutis Biotherapeutics

In partnership with the Skin of Color Society

Latanya T. Benjamin, MD and Adelaide A. Hebert, MD

9:00 AM – 9:05 AM Welcome to the Masters of Ped Derm

Lawrence A. Schachner, MD

9:05 AM – 9:30 AM

Schachner’s Therapeutic Update: What’s New in Ped Derm?

Lawrence A. Schachner, MD

9:30 AM – 11:30 AM Therapeutic Masterclass: Treatment Pearls

9:30 AM – 9:45 AM

10:30 AM – 10:45 AM

10:00 AM – 10:15 AM

10:15 AM – 10:30 AM

10:45 AM – 11:00 AM

9:45 AM – 10:00 AM

11:00 AM – 11:15 AM

11:15 AM – 11:30 AM

Vitiligo

Karan Lal, DO, MS, FAAD

Hyperhidrosis

Peter A. Lio, MD

Psoriasis

Elaine C. Siegfried, MD

Impetigo

Elaine C. Siegfried, MD

Alopecia Areata

Brittany G. Craiglow, MD

Molluscum Contagiosum

Mercedes E. Gonzalez, MD

Hidradenitis Suppurativa

Hadar Avihai Lev-Tov, MD, MAS

Wound Healing

Hadar Avihai Lev-Tov, MD, MAS

11:30 AM – 12:00 PM Exhibit and Networking Break

12:00 PM – 12:45 PM

Non-CME Lunch Symposium

Alopecia Areata: What You Need to Know

Sponsored by Pfizer

Brittany G. Craiglow, MD

12:45 PM – 1:15 PM Exhibit and Networking Break

AMERICANA FOYER

AMERICANA FOYER

AGENDA

1:15 PM - 2:45 PM

1:15 PM – 1:35 PM

1:35 PM – 1:55 PM

1:55 PM – 2:10 PM

Dermatologic Care for Adolescent Patients

Therapeutic Update: What’s Approved for Teens with Acne?

Jonette E. Keri, MD, PhD

Pearls for LGBTQ+ Patient Care

Klint Peebles, MD

Skin Manifestations of Sexually Transmitted Diseases

Theodore Rosen, MD

2:10 PM – 2:30 PM Do You Know JAK?

Brittany G. Craiglow, MD

2:30 PM – 2:45 PM

2:45 PM – 3:15 PM

3:15 PM - 3:50 PM

Psychosocial Effects of Skin Disease

Peter A. Lio, MD

Exhibit and Networking Break

Pigmented Skin Lesions

3:15 PM – 3:30 PM An Update on Pigmented Lesions in Children

3:30 PM – 3:50 PM

3:50 PM - 4:35 PM

3:50 PM – 4:05 PM

4:05 PM – 4:20 PM

4:20 PM – 4:35 PM

4:35 PM – 5:00 PM

Fernanda B. Schmidt, MD

Diagnostic Dermoscopy

Giuseppe Micali, MD

Filling in the Gaps in Pediatric Dermatology

Diagnosing Skin Conditions Across Fitzpatrick Skin Type

Mercedes E. Gonzalez, MD

Pediatric Dermatology Issues in the Inner City

Karan Lal, DO, MS, FAAD

Ped Derms Spread Far and Wide: Telemedicine for your Rural Patients

Anna L. Bruckner, MD

Expert vs Expert “Friendly Debate” Atopic Dermatitis

Moderator: Latanya T. Benjamin, MD

Peter A. Lio, MD and Giuseppe Micali, MD

5:00 PM – 6:00 PM Sips + Salsa – The Ultimate Miami Party

AMERICANA FOYER

AGENDA

8:00 AM – 9:00 AM

CME Satellite Breakfast Symposium

Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care

Supported by an educational grant from Pfizer

Brittany G. Craiglow, MD, Brett A. King, MD, PhD and Natasha A. Mesinkovska, MD, PhD

9:00 AM - 10:00 AM

9:00 AM – 9:15 AM

9:15 AM – 9:30 AM

9:30 AM – 9:45 AM

9:45 AM – 10:00 AM

10:00 AM - 10:45 AM

10:00 AM – 10:15 AM

10:15 AM – 10:30 AM

10:30 AM – 10:45 AM

10:45 AM – 11:15 AM

11:15 AM – 11:55 AM

Neonatal Dermatology

Challenges in Neonatal Skincare

Lawrence A. Schachner, MD

Infections in the Nursery

Fernanda B. Schmidt, MD

Pseudo-emergencies in the Nursery

Lawrence A. Schachner, MD

True Emergencies in the Nursery

Anna L. Bruckner, MD

Rare and Orphan Diseases

Overview of Congenital Ichthyoses

Fernanda B. Schmidt, MD

Epidermolysis Bullosa: How to Treat

Anna L. Bruckner, MD

How Morphea Behaves Over Time

Andrea D. Maderal, MD

Exhibit and Stretch Break

Perspectives on Atopic Dermatitis: A Caregiver-Clinician-Industry Panel (Non-CME)

In partnership with Global Parents for Eczema Research

Latanya T. Benjamin, MD

11:55 AM – 12:00 PM Stretch Break

12:00 PM – 12:45 PM Non-CME Lunch Symposium

A Treatment Option for Children with Uncontrolled Moderate-to-Severe Atopic Dermatitis

Sponsored by Sanofi and Regeneron Pharmaceuticals

Shivani Patel, MD

12:45 PM – 1:15 PM Exhibit and Networking Break

1:15 PM – 2:15 PM

CME Satellite Symposium

Infants and Atopic Dermatitis: The Biggest Help for the Smallest Patients

Supported by an educational grant from Sanofi and Regeneron Pharmaceuticals

In partnership with the Skin of Color Society

Mercedes E. Gonzalez, MD, Lawrence A. Schachner, MD Elaine C. Siegfried, MD

2:15 PM – 2:30 PM

2:30 PM – 2:45 PM

Cutaneous Manifestations of Systemic Diseases

Brittany G. Craiglow, MD

Collagen Vascular Diseases

Andrea D. Maderal, MD

AMERICANA FOYER

AMERICANA

www.livderm.org 5

AGENDA

2:45 PM – 3:15 PM Exhibit and Networking Break

3:15 PM – 3:40 PM

3:40 PM - 4:55 PM

3:40 PM – 3:55 PM

3:55 PM – 4:10 PM

4:10 PM – 4:25 PM

4:25 PM – 4:40 PM

4:40 PM – 4:55 PM

4:55 PM – 5:00 PM

5:00 PM – 6:00 PM

6:00 PM – 6:30 PM

Anticipatory Guidance for Children’s Skincare

Anna Nichols, MD, PhD

In-Depth Case Simulations

Moderator: Latanya T. Benjamin, MD

Atopic Dermatitis

Peter A. Lio, MD

Psoriasis

Elaine C. Siegfried, MD

Acne

Jonette E. Keri, MD, PhD

Vascular Lesions and Hemangioma

Mercedes E. Gonzalez, MD

Scabies and Lice

Giuseppe Micali, MD

Closing Remarks

Lawrence A. Schachner, MD

MOPD Reception

Non-CME Dinner Symposium

Sereneskin: Oral Spore-Based Probiotics In Non-Cystic Acne Vulgaris

Sponsored by Microbiome Labs

Thomas Bayne, DC

EXPERT SPEAKERS

SYMPOSIUM CHAIR

Lawrence A. Schachner, MD

Professor emeritus UM Miller School of Medicine

Pediatric Dermatologist

University of Miami Health System

Miami, Florida

EXPERT FACULTY

Anna Bruckner, MD, MS

Section Head, Dermatology

Children’s Hospital Colorado

Aurora, Colorado

Mercedes E. Gonzalez, MD

Medical Director

Pediatric Dermatology of Miami

Miami, Florida

Karan Lal, MD

Director of Pediatric and Cosmetic Dermatology

Affiliated Dermatology

Phoenix, Arizona

Brittany G. Craiglow, MD

Assistant Adjunct Professor of Dermatology

Yale School of Medicine New Haven, Connecticut

Jonette Keri, MD, PhD

Professor

University of Miami, Philip Frost

Department of Dermatology and Cutaneous Surgery

Dermatology Service Chief

Miami VA Hospital

Miami, Florida

Hadar Lev-Tov, MD

Associate professor

University of Miami

Miami, Florida

EXPERT SPEAKERS

Peter A. Lio, MD

Clinical Assistant Professor of Dermatology and Pediatrics

Northwestern University Feinberg School of Medicine

Chicago, Illinois

Giuseppe Micali, MD

Head, Director, Professor, Dermatologist

University of Catania Catania, Sicily, Italy

Klint Peebles, MD, FAAD

Dermatologist

Mid-Atlantic Permanente Medical Group

Washington, DC Fernanda B. Schmidt, MD

Assistant Professor

University of Miami Miami, FL

Andrea D. Maderal, MD

University of Miami Miller School of Medicine Assistant

Professor at Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery

Miami, FL

Anna Nichols, MD, PhD

Assistant Professor

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery

University of Miami Miller School of Medicine

Miami, Florida

Theodore Rosen, MD

Professor and Vice-Chair, Department of Dermatology

Baylor College of Medicine

Houston, Texas

Elaine C. Siegfried, MD

Director

Division of Pediatric Dermatology Professor

Pediatrics and Dermatology

Saint Louis University

St. Louis, Missouri

The 2022 MOPD Symposium gratefully acknowledges its partners:

PME SESSION

THURSDAY FEBRUARY 9

POINCIANA BALLROOM

12:00 PM - 12:45 PM

Alopecia Areata: What You Need to Know (Non-CME)

PRESENTED BY: Brittany G. Craiglow, MD

FRIDAY, FEBRUARY 10

POINCIANA BALLROOM

12:00 PM - 12:45 PM

A Treatment Option for Children with Uncontrolled Moderate-to-Severe Atopic Dermatitis (Non-CME)

PRESENTED BY: Shivani Patel, MD

6:00 PM - 6:30 PM

Sereneskin Oral Spore-Based Probiotics in Non-Cystic Acne Vulgaris (Non-CME)

PRESENTED BY: Thomas Bayne, DC

SPONSORED BY:

SPONSORED BY:

SPONSORED BY:

Almirall (3)

Comparison of patient and caregiver global assessment of acne severity among adolescent patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: Analysis of PROSES study results

Hilary Baldwin,1 Adelaide Hebert,2 Andrew F. Alexis,3 James Del Rosso,4 Richard G. Fried,5 Emmy Graber,6 Julie C. Harper,7 Leon Kircik,8 Evan A Rieder,9 Linda Stein Gold,10 Siva Narayanan,11 Volker Koscielny,12 Ismail Kasujee12

Changes in acne signs and impact of acne on emotions and social functioning, among pediatric patients with moderate to severe non-nodular acne vulgaris administrated sarecycline in real-world community practices across the U.S. (PROSES study)

Hilary Baldwin,1 Adelaide Hebert,2 Andrew F. Alexis,3 James Del Rosso,4 Richard G. Fried,5 Emmy Graber,6 Julie C. Harper,7 Leon Kircik,8 Evan A Rieder,9 Linda Stein Gold,10 Siva Narayanan,11 Volker Koscielny,12 Ismail Kasujee12

Changes in social functioning, emotional functioning, and activities of daily living (ADL) among pediatric patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in real-world community practices across the U.S. (PROSES Study)

Hilary Baldwin,1 Adelaide Hebert,2 Andrew F. Alexis,3 James Del Rosso,4 Richard G. Fried,5 Emmy Graber,6 Julie C. Harper,7 Leon Kircik,8 Evan A Rieder,9 Linda Stein Gold,10 Siva Narayanan,11 Volker Koscielny,12 Ismail Kasujee12

Alphabet Health (Leo Pharma) (2)

Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial

Andreas Wollenberg1,2, Marjolein de Bruin-Weller3, Jacob P. Thyssen4, Lisa A. Beck5, Eric L. Simpson6, Shinichi Imafuku7, Mark Boguniewicz8, Azra Kurbasic9, Lise Soldbro9, Natacha

Strange Vest9, Petra Arlert9, Amy S. Paller10

Safety of tralokinumab in pediatric patients aged 12–17 with moderate-to-severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial

Andreas Wollenberg, Michael Cork, Carsten Flohr, Anthony Bewley, Andrew Blauvelt, Chih-ho Hong, Shinichi Imafuku, Marie L.A. Schuttelaar, Eric L. Simpson, Weily Soong, Petra Arlert, Katja Lophaven, Azra Kurbasic, Lise Soldbro, Natacha Strange Vest, Amy Paller

Alphyn Biologics

Evaluation of a novel, anti-inflammatory, anti-pruritic and anti-S. aureus/MRSA topical drug in phase

2 clinical trial with favorable safety profile potentially beneficial for atopic dermatitis

Neal Koller, Alphyn Biologics

Gary Pekoe, PhD, Alphyn Biologics

CeraVe (3)

Promoting a healthy skin barrier using skin care in people with mature skin xerosis

Michael Gold MD FAAD(a) Anneke Andriessen PhD,(b) Cheryl Burgess MD FAAD,(c) Valerie Callender MD FAAD,(d) David Goldberg MD JD FAAD,(e) Firas Hougeir MD FAAD,(f) Leon Kircik MD FAAD,(g) Todd Schlesinger MD FAAD (h)

Improvement of venous dermatitis-related leg xerosis with ceramides-containing cleansers and moisturizers – an expert-based consensus

Robert S. Kirsner MD PhD(a), Anneke Andriessen PhD(b), Jason R. Hanft DPM FACFAS(c), Shasa Hu MD FAAD(a), William A. Marston MD Vascular Surgeon(d), Lee C. Ruotsi MD ABWMS

CWS-P UHM(e), Gil Yosipovitch MD FAAD(a)

Dermatology in the social media era: Building awareness on social media’s impact on adolescent skin disease and mental health

Evan E Rieder MD FAAD(a), Anneke Andriessen PhD(b), Vanessa Cutler MD(c), Mercedez E Gonzalez MD FAAD(d), Jennifer L Greenberg PsyD(e), Peter Lio MD FAAD(f), Elyse M Love MD(g), Vikash Oza(h) MD FAAD, Joyce Park MD(i), Katharine A Phillips MD(j)

Nobel Pharma (1)

Development of Consensus Statements for Treatment of Facial Angiofibroma Associated with Tuberous Sclerosis Complex

Lawrence Schachner, MD – University of Miami Miller School of Medicine. Miami, FL

Steven Sparagana, MD, FAAN – Scottish Rite for Children. Dallas, TX

Bernard Cohen, MD – Johns Hopkins School of Medicine. Baltimore, MD

Latanya Benjamin, MD, FAAD, FAAP – Florida Atlantic University, Boca Raton, FL

Mercedes E. Gonzalez, MD – Pediatric Skin Research and University of Miami Miller School of Medicine. Miami, FL

Adelaide Hebert, MD – UTHealth McGovern Medical School. Houston, TX

Lawrence Eichenfield, MD – UC San Diego School of Medicine. San Diego, FL

Elaine Siegfried, MD – SSM Health Cardinal Glennon Children’s Hospital. St. Louis, MO

Eric Beresford, PharmD, BCMAS – Nobelpharma America, LLC. Bethesda, MD

SYMPOSIA LISTING

THURSDAY FEBRUARY 9, 2023

8:00 AM – 9:00 AM |

POINCIANA

A NEW AGE IN PEDIATRIC PSORIASIS: CASE-BASED LEARNING FOR INCLUSIVE CARE

Latanya T. Benjamin, MD, Adelaide A. Hebert, MD

Supported by an educational grant from Arcutis Biotherapeutics

In partnership with the Skin of Color Society

FRIDAY FEBRUARY 10, 2023

8:00 AM – 9:00 AM | AMERICANA 1/2

GAMECHANGERS IN ALOPECIA AREATA: TARGETED THERAPIES FOR PATIENTCENTERED CARE

Brittany G. Craiglow, MD, Brett A. King, MD, PhD, Natasha A. Mesinkovska, MD, PhD

Supported by an educational grant from Pfizer

1:15 PM – 2:15 PM |

POINCIANA

INFANTS AND ATOPIC DERMATITIS: THE BIGGEST HELP FOR THE SMALLEST PATIENTS

Mercedes E. Gonzalez, MD, Lawrence A. Schachner, MD, Elaine C. Siegfried, MD

Supported by an educational grant from Sanofi and Regeneron Pharmaceuticals

In partnership with the Skin of Color Society

PARTNERS

MOPD FLOOR PLAN 2023

Alphyn Biologics, Inc. Booth 16

3724 Thomas Point Rd

Annapolis, Maryland 21403 +1 (410) 690-8687

http://www.alphynbiologics.com nkoller@alphynbiologics.com

Alphyn Biologics is developing first-in-class multi-target therapeutics for severe and prevalent skin diseases using its AB-101 drug substance. Lead product candidate, AB-101a, is a topical drug for atopic dermatitis (AD), which just completed a Phase 2a clinical trial in pediatric (starting at 2 years old) and adult patients. AB-101a uniquely targets AD’s immune system and bacterial components, and has strong safety / side effect profile, which combined, suggest it to be a promising AD therapeutic.

Amryt Booth 7

160 Federal Street, 21st Floor Boston, Massachusetts 2110 +353 1 518 0200

https://amrytpharma.com/ medinfo@amrytpharma.com

Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets.

Beiersdorf Booth 17

15th floor

Stamford, Connecticut 6901 (203) 521-2809

http://www.beiersdorfmd.com deb.burattini@beiersdorf.com

Beiersdorf is a global leader in therapeutic skin care products. Visit our booth to learn about our innovations along with our existing Eucerin ® & Aquaphor® Products.

Bright Girl by Angela Casey MD Booth 19

5148 Abbotsbury Ct New Albany, Ohio 43054 (614) 735-3062

http://www.brightgirl.com drangela@brightgirl.com

Bright Girl by Angela Casey, M.D. is a Dermatologist-developed skincare line created specifically for girls ages 8+ Gentle, nourishing, pH-balanced formulations have clean ingredients and help young girls establish lifetime skincare habits to protect against skin cancer and premature aging. The Bright Girl collection consists of six products: SPF 44 Mineral Tinted Sunscreen, SPF 47 Sheer Mineral Sunscreen, Cleanser, Toner, Face Cream, Face Mask.

CeraVe Booth 21

10 Hudson Yards

New York, New York 10001

N/A

https://ceravepediatrics.com/ megan.manco@loreal.com

Developed with dermatologists, including pediatric dermatologists, CeraVe is committed to developing dermatological skincare solutions for every age and stage. All CeraVe products are formulated with ceramides 1, 3, & 6-II to help maintain and restore the skin’s natural protective barrier.

Chemistry Rx Booth 18

950 Henderson Blvd., Suite A Folcroft, Pennsylvania 19032-1805 (855) 790-0100

http://www.chemistryrx.com lars@chemistryrx.com

Chemistry Rx is an accredited compounding pharmacy licensed in all US states and territories focusing on treatment modalities for dermatologic conditions. One of our specialties is compounded medication for hair loss, including female and male pattern alopecia, scarring alopecia and alopecia areata. We design highly innovative medications for topical and oral administration, as well as our newest product-- an in-office intradermal injection for both female and male patients with pattern alopecia.

Dermavant Sciences, Inc. Booth 10

2102 E. State Highway 114,Floor 2, Suite 217 Southlake, Texas 76092 (8DE) RMA-VANT

http://www.dermavant.com medinfo@dermavant.com

DERMAVANT. Innovating. Pioneering. Transforming. Dermavant is committed to fostering unprecedented change and unparalleled impact in immunodermatology. We’re doing this by thinking differently, pushing the boundaries of science and partnering with providers in new ways — all with one goal: Improving the lives of millions of patients with skin diseases. Learn more about who we are and the product candidates we’re developing at Dermavant.com. Please contact medinfo@ dermavant.com with any inquiries.

Krystal Bio Booth 12

34 Farnsworth Street, Suite 400 Boston, Massachusetts 2210 (412) 586-5830

http://www.krystalbio.com inquiries@krystalbio.com

Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary platform to develop effective and innovative treatments for genetic skin and other diseases. Our goal is to make a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases. We work to accomplish this goal through scientific innovation and operational excellence, believing that “nature operates in the shortest way possible” (Aristotle).

Microbiome Labs Booth 2

1332 Waukegan Rd Glenview, Illinois 60025 (904) 940-2208

https://microbiomelabs.com/home/ info@gomegaspore.com

At Microbiome Labs, we pioneer health by connecting the dots of the human biological system, so we can discover new solutions that revolutionize healthcare. As your practice partner, we strive to help and support through education, inspiration, and by bridging the therapeutic gaps of what global consumers—who face ever-growing modern life health challenges—need for healing.

Mustela Booth 11

60 East 56th Street New York, New York 10022 (212) 605-9968

http://www.mustelamd.com ekim@expanscience.com

Mustela draws upon its 70 years of dermatological expertise, decades of research and knowledge about the physiology of the skin to create innovative skincare products for babies, children and the whole family. Mustela is committed to skin health and uses safe, effective, and natural ingredients in its products, sourcing an average of 97% of natural ingredients All products are dermatologically tested, hypoallergenic, and will never include any questionable ingredients such as parabens, phthalates or phenoxyethanol.

NAOS Booth 15

NAOS Amérique du Nord - 800 boulevard de Maisonneuve Est,bureau 1200 Montréal, Quebec H2L 4L8 (438) 825-0970

http://naos.com/en/ julie.dillenschneider@us.naos.com

NAOS is a major player in skin care through its three brands: Bioderma (ecobiology at the service of dermatology), Institut Esthederm (ecobiology at the service of aesthetics) and Etat Pur (ecobiology at the service of personalized Skincare). NAOS puts biology at the heart of its innovation and develops around the principle of ecobiology, which considers the skin as an evolving ecosystem interacting with its environment and whose resources and natural mechanisms must be preserved.

4520 East West Hwy, suite 400 Bethesda, Maryland 20814 (301) 244-5951

https://www.nobelpharma-us.com/ brian.vautier@nobelpharma-us.com

Nobelpharma America, LLC is focused on the commercialization of pharmaceuticals and medical devices that expand treatment options for people with rare diseases. Nobelpharma America was established in 2019 as the first wholly owned global subsidiary of Nobelpharma Co., Ltd., based in Tokyo Japan. In 2022, Nobelpharma America’s first product received FDA approval and launched in the U.S. Please visit our booth for more information.

Nobel Pharma America Booth 1 & 6

11550 Meredian Street, Suite 175 Carmel, Indiana 46032 (317) 810-6240

https://www.parapro.com/ madelynp@parapro.com

Since 2002, ParaPRO has advanced the clinical drug development and utility of Spinosad, a novel compound derived from a naturally occurring soil microorganism, to effectively address the unmet needs of medical conditions associated with human parasites such as scabies and head lice. Our purpose is clear: to bring the latest technology, science, and clinical expertise to bear to ensure the safety and health outcomes of the patients and practitioners we serve.

Pfizer Inc. Booth 8

235 E 42nd St. New York, New York 10017 (800) 879-3477

http://www.pfizer.com www.pfizer.com

Pfizer Inc.: Breakthroughs that change patients’ lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

8 campus Drive Parsipanny, New Jersey 7054 (973) 355-8018

https://hemangeol.com/hcp/ nicole.barr@pierre-fabre.com

Discover HEMANGEOL- The First and Only FDA-Approved Treatment for Proliferating Infantile Hemangioma Requiring Systemic Therapy

Primus Pharmaceuticals Booth 4

7373 N. Scottsdale Road Suite B 200, Scottsdale, Arizona 85235 (480) 482-1410

http://primusrx.com

rkeating@primusrx.com

Primus Pharmaceuticals is a specialty pharmaceutical company the uses time-tested medical ingredients to fill today’s unmet medical needs. Utilizing a variety of products such as topical dermatology drugs, a medical device, and medical foods, Primus is meeting the needs of patients safely, without compromising efficacy. Our Topical Dermatological drugs provide elegant proprietary delivery systems superior to generics with greater patient acceptance and persistency.

ParaPro Booth 20

Pierre Fabre Booth 9

777 Old Saw Mill River Road Tarrytown, New York 10591 (914) 847-7000

https://www.dupixenthcp.com/ medical.information@regeneron.com

Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments. Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.

1928 Kellogg Ave, Carlsbad, California 92008 (619) 894-6540

https://tubbytodd.com/ customercare@tubbytodd.com

Tubby Todd was founded in 2014 by Andrea and Brian Williams. Created with sensitive-skinned babies in mind, each product is specially formulated to nourish, hydrate, and gently soothe skin from head to toe. Our FDA approved, All Over Ointment, is a sensitive skin super balm that has proven to be a successful remedy for eczema, dryness and irritation based on reviews from thousands of families. Visit www.tubbytodd.com to see more.

44 W. Gay Street, Suite 400, West Chester, Pennsylvania 19380 (610) 329-9217

http://www.verrica.com tcavallo@verrica.com

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. VP-102, our lead product candidate, is a drug-device combination topical therapy that has the potential to be the first product approved by the FDA to treat molluscum contagiosum (molluscum).

Sanofi and Regeneron Booth 13 & 14

Tubby Todd Bath Co.

Verrica Booth 3

Support your clients' gut-skin axis, no matter their skin type or color

Introducing SereneSkin™, innovative support for the skin microbiome:

Helps skin retain moisture Supports clear skin

Resolves occasional non-cystic acne

Addresses fine lines and wrinkles Supports the gut-skin axis

HARNESS THE POWER OF PROBIOTIC SKINCARE WITH SERENESKIN

™

LEARN MORE AT MICROBIOMELABS.COM

FDA STATEMENT: THESE STATEMENTS HAVE NOT YET BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION (FDA). THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.